Abstract:Objective: Mutations to the BSCL2 gene disrupt the protein seipin and cause the most severe form of congenital generalised lipodystrophy (CGL). Affected individuals exhibit a near complete loss of white adipose tissue (WAT) and suffer from metabolic disease. Seipin is critical for adipocyte development in culture and mice with germline disruption to Bscl2 recapitulate the effects of BSCL2 disruption in humans. Here we examined whether loss of Bscl2 specifically in developing adipocytes in vivo is sufficient to prevent adipose tissue development and cause all features observed with congenital BSCL2 disruption. Methods: We generated and characterised a novel mouse model of Bscl2 deficiency in developing adipocytes (Ad-B2((-/-))) using the adiposespecific Adiponectin-Cre line. Results: We demonstrate that Ad-B2((-/-)) mice display early onset lipodystrophy, in common with congenital Bscl2 null mice and CGL2 patients. However, glucose intolerance, insulin resistance, and severe hepatic steatosis are not apparent. Food intake and energy expenditure are unchanged, but Ad-B2((-/-)) mice exhibit significantly altered substrate utilisation. We also find differential effects of seipin loss between specific adipose depots revealing new insights regarding their varied characteristics. When fed a high-fat diet, Ad-B2((-/-)) mice entirely fail to expand adipose mass but remain glucose tolerant. Conclusions: Our findings demonstrate that disruption of Bscl2 specifically in developing adipocytes is sufficient to cause the early-onset generalised lipodystrophy observed in patients with mutations in BSCL2. However, this significant reduction in adipose mass does not cause the overt metabolic dysfunction seen in Bscl2 knockout mice, even following a high-fat diet challenge. (C) 2018 The Authors. Published by Elsevier GmbH.

Role of Seipin in Human Diseases and Experimental Animal Models

Towards a mechanistic understanding of lipodystrophy and seipin functions.

Seipin Ablation in Mice Results in Severe Generalized Lipodystrophy

Seipin differentially regulates lipogenesis and adipogenesis through a conserved core sequence and an evolutionarily acquired C-terminus.

Effects of seipin on mouse mesenchymal stem cell Osteo-Adipogenic Balance

Overexpression of a Short Human Seipin/bscl2 Isoform in Mouse Adipose Tissue Results in Mild Lipodystrophy.

SEIPIN Regulates Lipid Droplet Expansion and Adipocyte Development by Modulating the Activity of Glycerol-3-phosphate Acyltransferase

Hepatic BSCL2 (Seipin) Deficiency Disrupts Lipid Droplet Homeostasis and Increases Lipid Metabolism via SCD1 Activity

Molecular Characterization of Seipin and Its Mutants: Implications for Seipin in Triacylglycerol Synthesis.

Adipose Specific Disruption of Seipin Causes Early-Onset Generalised Lipodystrophy and Altered Fuel Utilisation Without Severe Metabolic Disease.

Expression of Seipin in Adipose Tissue Rescues Lipodystrophy, Hepatic Steatosis and Insulin Resistance in Seipin Null Mice

Adipose-specific Knockout of SEIPIN/BSCL2 Results in Progressive Lipodystrophy.

Seipin regulates lipid homeostasis by ensuring calcium-dependent mitochondrial metabolism.

Seipin regulates excitatory synaptic transmission in cortical neurons.

Seipin deficiency-induced lipid dysregulation leads to hypomyelination-associated cognitive deficits via compromising oligodendrocyte precursor cell differentiation

Identification of genetic suppressors for a BSCL2 lipodystrophy pathogenic variant in Caenorhabditis elegans

Tissue-autonomous Function of Drosophila Seipin in Preventing Ectopic Lipid Droplet Formation.

A study of congenital generalized lipodystrophy (CGL) caused by BSCL2 gene mutation

Loss of the seipin gene perturbs eggshell formation in Caenorhabditiselegans

Seipin Deficiency Leads to Energy Dyshomeostasis via Inducing Hypothalamic Neuroinflammation and Aberrant Expression of Neuropeptides

Seipin deletion in mice enhances phosphorylation and aggregation of tau protein through reduced neuronal PPARγ and insulin resistance